These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 25049259)

  • 1. Repurposing the open access malaria box to discover potent inhibitors of Toxoplasma gondii and Entamoeba histolytica.
    Boyom FF; Fokou PV; Tchokouaha LR; Spangenberg T; Mfopa AN; Kouipou RM; Mbouna CJ; Donfack VF; Zollo PH
    Antimicrob Agents Chemother; 2014 Oct; 58(10):5848-54. PubMed ID: 25049259
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Discovery of New Inhibitors of Toxoplasma gondii via the Pathogen Box.
    Spalenka J; Escotte-Binet S; Bakiri A; Hubert J; Renault JH; Velard F; Duchateau S; Aubert D; Huguenin A; Villena I
    Antimicrob Agents Chemother; 2018 Feb; 62(2):. PubMed ID: 29133550
    [No Abstract]   [Full Text] [Related]  

  • 3. Discovery of Antiamebic Compounds That Inhibit Cysteine Synthase From the Enteric Parasitic Protist
    Mori M; Tsuge S; Fukasawa W; Jeelani G; Nakada-Tsukui K; Nonaka K; Matsumoto A; Ōmura S; Nozaki T; Shiomi K
    Front Cell Infect Microbiol; 2018; 8():409. PubMed ID: 30568921
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Quassinoids exhibit greater selectivity against Plasmodium falciparum than against Entamoeba histolytica, Giardia intestinalis or Toxoplasma gondii in vitro.
    Wright CW; Anderson MM; Allen D; Phillipson JD; Kirby GC; Warhurst DC; Chang HR
    J Eukaryot Microbiol; 1993; 40(3):244-6. PubMed ID: 8508162
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of fungal natural products with potent inhibition in
    Jiang T; Godinez-Macias KP; Collins JE; Lee JW; Wendt KL; Carolino K; Chakrabarti D; Cichewicz RH; Winzeler EA
    Microbiol Spectr; 2024 Apr; 12(4):e0414223. PubMed ID: 38421191
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Repurposing the Medicines for Malaria Venture's COVID Box to discover potent inhibitors of Toxoplasma gondii, and in vivo efficacy evaluation of almitrine bismesylate (MMV1804175) in chronically infected mice.
    Dos Santos BR; Ramos ABDSB; de Menezes RPB; Scotti MT; Colombo FA; Marques MJ; Reimão JQ
    PLoS One; 2023; 18(7):e0288335. PubMed ID: 37418497
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of Cryptosporidium parvum active chemical series by Repurposing the open access malaria box.
    Bessoff K; Spangenberg T; Foderaro JE; Jumani RS; Ward GE; Huston CD
    Antimicrob Agents Chemother; 2014 May; 58(5):2731-9. PubMed ID: 24566188
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Targeted Phenotypic Screening in
    Subramanian G; Belekar MA; Shukla A; Tong JX; Sinha A; Chu TTT; Kulkarni AS; Preiser PR; Reddy DS; Tan KSW; Shanmugam D; Chandramohanadas R
    mSphere; 2018; 3(1):. PubMed ID: 29359192
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Modification of triclosan scaffold in search of improved inhibitors for enoyl-acyl carrier protein (ACP) reductase in Toxoplasma gondii.
    Stec J; Fomovska A; Afanador GA; Muench SP; Zhou Y; Lai BS; El Bissati K; Hickman MR; Lee PJ; Leed SE; Auschwitz JM; Sommervile C; Woods S; Roberts CW; Rice D; Prigge ST; McLeod R; Kozikowski AP
    ChemMedChem; 2013 Jul; 8(7):1138-60. PubMed ID: 23776166
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Two old drugs, NVP-AEW541 and GSK-J4, repurposed against the Toxoplasma gondii RH strain.
    Liu S; Wu M; Hua Q; Lu D; Tian Y; Yu H; Cheng L; Chen Y; Cao J; Hu X; Tan F
    Parasit Vectors; 2020 May; 13(1):242. PubMed ID: 32393321
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Design, synthesis and biological evaluation of sulfur-containing 1,1-bisphosphonic acids as antiparasitic agents.
    Recher M; Barboza AP; Li ZH; Galizzi M; Ferrer-Casal M; Szajnman SH; Docampo R; Moreno SN; Rodriguez JB
    Eur J Med Chem; 2013 Feb; 60():431-40. PubMed ID: 23318904
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In Vitro Anti-Toxoplasma gondii Activity Evaluation of a New Series of Quinazolin-4(3H)-one Derivatives.
    Deng Y; Mu H; Li HB; Fu LZ; Tang D; Wu T; Huang SH; Li CH
    Chem Biodivers; 2021 Dec; 18(12):e2100687. PubMed ID: 34726832
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anti-
    Dos Santos BR; Ramos ABDSB; de Menezes RPB; Scotti MT; Colombo FA; Marques MJ; Reimão JQ
    Parasitology; 2023 Nov; 150(13):1226-1235. PubMed ID: 37859414
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Sensibility of Entamoeba histolytica trophozoites to ivermectin].
    González-Salazar F; Mata-Cárdenas BD; Vargas-Villareal J
    Medicina (B Aires); 2009; 69(3):318-20. PubMed ID: 19622479
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of the antiprotozoal activity of neo-clerodane type diterpenes from Salvia polystachya against Entamoeba histolytica and Giardia lamblia.
    Calzada F; Yepez-Mulia L; Tapia-Contreras A; Bautista E; Maldonado E; Ortega A
    Phytother Res; 2010 May; 24(5):662-5. PubMed ID: 19610033
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antiprotozoal activity of chloroquinoline based chalcones.
    Hayat F; Moseley E; Salahuddin A; Van Zyl RL; Azam A
    Eur J Med Chem; 2011 May; 46(5):1897-905. PubMed ID: 21377771
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterization of Entamoeba histolytica adenosine 5'-phosphosulfate (APS) kinase; validation as a target and provision of leads for the development of new drugs against amoebiasis.
    Mi-Ichi F; Ishikawa T; Tam VK; Deloer S; Hamano S; Hamada T; Yoshida H
    PLoS Negl Trop Dis; 2019 Aug; 13(8):e0007633. PubMed ID: 31425516
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vitro susceptibility of Entamoeba histolytica and Giardia lamblia to plants used in Mexican traditional medicine for the treatment of gastrointestinal disorders.
    Calzada F; Yépez-Mulia L; Aguilar A
    J Ethnopharmacol; 2006 Dec; 108(3):367-70. PubMed ID: 16846708
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthesis and biological evaluation of anti-Toxoplasma gondii activity of a novel scaffold of thiazolidinone derivatives.
    Carradori S; Secci D; Bizzarri B; Chimenti P; De Monte C; Guglielmi P; Campestre C; Rivanera D; Bordón C; Jones-Brando L
    J Enzyme Inhib Med Chem; 2017 Dec; 32(1):746-758. PubMed ID: 28537532
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antiprotozoal Activity against
    Quintanilla-Licea R; Vargas-Villarreal J; Verde-Star MJ; Rivas-Galindo VM; Torres-Hernández ÁD
    Molecules; 2020 May; 25(11):. PubMed ID: 32466359
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.